Author | Sumanta K. Pal, MD, City of Hope Comprehensive Cancer Center | OncLive

Author | Sumanta K. Pal, MD, City of Hope Comprehensive Cancer Center

Articles

Dr. Pal on the Rationale for Adding Cabozantinib to Atezolizumab in Prostate Cancer

February 19, 2020

Video

Sumanta K. Pal, MD, discusses the rationale for adding cabozantinib to atezolizumab in prostate cancer.

Dr. Pal on Cohort Findings of COSMIC-021 Trial in mCRPC

February 14, 2020

Video

Sumanta K. Pal, MD, associate clinical professor, Department of Medical Oncology and Therapeutics Research, co-director, Kidney Cancer Program, medical oncologist, City of Hope, discusses the phase Ib results of cohort 6 from the COSMIC-021 trial in patients with metastatic castration-resistant prostate cancer.

Dr. Pal Compares CheckMate-214 and CABOSUN Trials in RCC

September 13, 2017

Video

Sumanta K. Pal, MD, medical oncologist, assistant clinical professor, Department of Medical Oncology and Therapeutics Research, City of Hope, discusses both the CheckMate-214 and CABOSUN trials for patients with renal cell carcinoma (RCC).

x